ArticleJournal of feline medicine and surgery2025
Retrospective study of biochemical profile changes in 93 cats with different hepatobiliary diseases.
Article in Journal of feline medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodality imaging characteristics and surgical management of a biliary cystadenoma in a cat.Veterinary research communications · 2026Article
- Evaluation of Serum Homocysteine and High-Sensitivity Cardiac Troponins in Cats with Hepatic Lipidosis: An Observational Clinical Study.Veterinary sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivesThis study aims to assess hepatic clinicopathological changes in cats with different hepatobiliary diseases and to assess whether specific serum biochemistry changes can help differentiate these diseases.MethodsA retrospective analysis was conducted on serum biochemistry data from 93 cats with hepatobiliary diseases and 80 control cats. Of the 93 cats with definitive diagnoses of hepatobiliary diseases, 22 had cholangitis, 14 had hepatic lipidosis, 18 had primary hepatic neoplasia confirmed via Tru-cut or laparotomic wedge biopsy and 39 had congenital portosystemic shunting (CPSS) confirmed by abdominal ultrasound. The biomarkers analysed were alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyl-transferase (GGT), total bilirubin and albumin.ResultsCats with hepatobiliary disease had significantly higher enzyme activities, total bilirubin concentrations and lower albumin concentrations compared with controls (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.